Detalhe da pesquisa
1.
Bioequivalence study followed by model-informed dose optimization of a powder for oral suspension of 6-mercaptopurine.
Pediatr Blood Cancer
; 71(3): e30813, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110844